EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Iran's Escherichia coli AMR Landscape (2010–2025): A One Health Systematic Review and Meta‐Analysis

Arezoo Dehghan iD, Mina Arabian, Zahra Tahmasebi iD, Aliasghar Fakhri-Demeshghieh iD, Neda Baseri, Ehsan Mostafavi iD, Farzad Badmasti iD, Faranak Abnaroodhelleh, Arash Seifi, Fahimeh Bagheri Amiri iD

MicrobiologyOpen · 2026

DOI: 10.1002/mbo3.70420 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift MicrobiologyOpen, 2026. Verfasst von Arezoo Dehghan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, WHO Collaborating Center for Vector-Borne Diseases, Research Centre for Emerging and Reemerging Infecti…. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents, Escherichia coli Infections, Drug Resistance, Multiple, Bacterial. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Escherichia coli ( E. coli ) has developed resistance to multiple antibiotic classes, complicating treatment in both human and veterinary medicine. This study assesses the prevalence of antimicrobial resistance and antimicrobial resistance genes in E. coli in Iran, within a One Health framework encompassing humans, animals, foods, and the environment. We systematically searched Scopus, Google Scholar, Magiran, PubMed, Scientific Information Database Library (SID), and Web of Science, using keywords related to AMR and Escherichia coli , restricting to English and Persian publications from 2010 to January 2025. The risk of bias was evaluated using the JBI checklist for prevalence studies. Pooled prevalence and 95% confidence intervals (CIs) were calculated for each antibiotic using random‐effects models. A total of 368 studies were included in the meta‐analysis. The highest resistance was observed in the Classes of Penicillins (71.7, 95% CI: 65.6–76.6) and the lowest for Fosfomycins (6.8, 95% CI: 5.2–8.5). Resistance to Ceftizoxime, Ertapenem, Streptomycin, Piperacillin‐Tazobactam, and Colistin increased over time. Phenotypically, 47.2%, 20.2%, and 14.1% of E. coli isolates were identified as extended‐spectrum β‐lactamase‐producing (ESBL), AmpC, and metallo‐beta‐lactamase (MBL) producing, respectively. Among ESBL‐producing isolates, the prevalence of bla CTX‐M , bla TEM , and bla SHV genes was 68.2%, 58.5%, and 24.4%, respectively. The high prevalence of AMR highlights the critical need for robust antimicrobial stewardship within a One Health framework to preserve antibiotic efficacy. Our study provides essential baseline data across human, animal, and environmental sectors in Iran, forming a basis for future One Health strategies and policy‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliAnti-Bacterial AgentsEscherichia coli InfectionsDrug Resistance, Multiple, BacterialDrug Resistance, BacterialHumansIranAnimalsOne HealthMicrobial Sensitivity Testsbeta-LactamasesPrevalence

Stichwörter der Autor:innen

Escherichia coliIranantimicrobial resistanceone health

Substanzen

Anti-Bacterial Agentsbeta-Lactamases

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, WHO Collaborating Center for Vector-Borne Diseases, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
  • Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
  • Head of the Control and Supervision Group on the Production of Medicines and Biological Materials of the Iran Veterinary Organization, Tehran, Iran.
  • Center for Communicable Diseases Control (CDC), Ministry of Health and Medical Education, Tehran, Iran.
  • Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Infectious Diseases Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Arezoo Dehghan, Zahra Tahmasebi, Aliasghar Fakhri-Demeshghieh, Ehsan Mostafavi, Farzad Badmasti, Fahimeh Bagheri Amiri

Zitieren

APA

Dehghan, A., Arabian, M., Tahmasebi, Z., Fakhri-Demeshghieh, A., Baseri, N., Mostafavi, E., Badmasti, F., Abnaroodhelleh, F., Seifi, A., & Bagheri Amiri, F. (2026). Iran's Escherichia coli AMR Landscape (2010–2025): A One Health Systematic Review and Meta‐Analysis. MicrobiologyOpen. https://doi.org/10.1002/mbo3.70420

Vancouver

Dehghan A, Arabian M, Tahmasebi Z, Fakhri-Demeshghieh A, Baseri N, Mostafavi E, et al. Iran's Escherichia coli AMR Landscape (2010–2025): A One Health Systematic Review and Meta‐Analysis. MicrobiologyOpen. 2026. doi:10.1002/mbo3.70420

BibTeX
@article{Dehghan2026,
  author = {Dehghan, Arezoo and Arabian, Mina and Tahmasebi, Zahra and Fakhri-Demeshghieh, Aliasghar and Baseri, Neda and Mostafavi, Ehsan and Badmasti, Farzad and Abnaroodhelleh, Faranak and Seifi, Arash and Bagheri Amiri, Fahimeh},
  title = {Iran's Escherichia coli AMR Landscape (2010–2025): A One Health Systematic Review and Meta‐Analysis},
  journal = {MicrobiologyOpen},
  year = {2026},
  doi = {10.1002/mbo3.70420}
}
Kostenlos starten →